Related Experiment Videos
Fimbria-specific antibodies detach Escherichia coli from human cells
Abstract:
Antibodies obtained from rabbits immunized with purified adhesion-mediating fimbriae of Escherichia coli SS142 were specific for the fimbriae of the homologous strain; they did not cross-react with isolated fimbriae of three different E. coli strains or with protein extracts from nine other adhesive E. coli strains. The antibodies inhibited adhesion to Intestine 407 tissue culture cell monolayers and hemagglutinating activity of E. coli SS142 but not of several other E. coli strains. The antibodies were able not only to prevent but also to reverse the adhesion of E. coli SS142 to Intestine 407 cells or human erythrocytes. Analysis of the kinetics of inhibition suggested that the antibodies did not competitively inhibit adhesion. Such antibodies can be useful for distinguishing different mechanistic steps of bacterial adhesion. Their ability to reverse bacterial adhesion in vitro may be of clinical relevance.
Insights
Researchers developed specific antibodies against Escherichia coli SS142 fimbriae. These antibodies effectively blocked and reversed bacterial adhesion, showing potential clinical relevance for treating infections.
Area of Science:
- Microbiology
- Immunology
- Bacterial Adhesion Mechanisms
Background:
- Escherichia coli (E. coli) utilizes adhesion-mediating fimbriae for host cell attachment.
- Understanding the specific interactions of bacterial fimbriae is crucial for developing targeted therapies.
Purpose of the Study:
- To generate and characterize antibodies specific to the adhesion fimbriae of Escherichia coli SS142.
- To investigate the efficacy of these antibodies in inhibiting and reversing bacterial adhesion in vitro.
Main Methods:
- Immunization of rabbits with purified E. coli SS142 fimbriae to produce polyclonal antibodies.
- Testing antibody specificity against various E. coli strains using Western blot and immunoprecipitation.
- Assessing antibody function through inhibition and reversal assays of bacterial adhesion to cell monolayers and erythrocytes.
- Analyzing adhesion kinetics to determine the mechanism of inhibition.
Main Results:
- Generated antibodies were highly specific to E. coli SS142 fimbriae, showing no cross-reactivity with other E. coli strains.
- Antibodies significantly inhibited hemagglutination and adhesion of E. coli SS142 to Intestine 407 cells.
- Antibodies demonstrated the ability to not only prevent but also reverse established bacterial adhesion.
- Kinetic analysis indicated that antibody inhibition was non-competitive.
Conclusions:
- Specific antibodies targeting E. coli SS142 fimbriae are effective in blocking and reversing bacterial adhesion.
- These antibodies offer a valuable tool for dissecting bacterial adhesion mechanisms.
- The capacity to reverse adhesion suggests potential therapeutic applications in managing E. coli infections.